Literature DB >> 24192800

Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease.

Petronella G Pieper1, Ali Balci, Jan G Aarnoudse, Marlies A M Kampman, Krystyna M Sollie, Henk Groen, Barbara J M Mulder, Martijn A Oudijk, Jolien W Roos-Hesselink, Jerome Cornette, Arie P J van Dijk, Marc E Spaanderman, Willem Drenthen, Dirk J van Veldhuisen.   

Abstract

BACKGROUND: Pregnant women with congenital heart disease (CHD) are susceptible to cardiovascular, obstetric, and offspring complications. In women with CHD, cardiac dysfunction may compromise uteroplacental flow and contribute to the increased incidence of obstetric and offspring events. METHODS AND
RESULTS: We performed a prospective multicenter cohort study of pregnant women with CHD and healthy pregnant women. We compared clinical, laboratory, echocardiographic, and uteroplacental Doppler flow (UDF) parameters at 20 and 32 weeks gestation, and pregnancy outcome. We related cardiovascular parameters to UDF parameters and pregnancy outcome in women with CHD. We included 209 women with CHD and 70 healthy women. Cardiovascular parameters (N-terminal pro-B-type natriuretic peptide, left and right ventricular function) differed between both groups. UDF parameters were impaired in CHD women (umbilical artery pulsatility and resistance index at 32 weeks in CHD versus healthy women, P=0.0085 and P=0.017). The following cardiovascular parameters prepregnancy and at 20 weeks gestation were associated with UDF (umbilical artery resistance index) at 32 weeks at multivariable analysis: (1) right ventricular function (tricuspid annular plane systolic excursion) (P=0.002), (2) high N-terminal pro-B-type natriuretic peptide (P=0.085), (3) systemic (P=0.001), and (4) pulmonary (P=0.045) atrioventricular valve regurgitation. Women with CHD had more obstetric (58.9% versus 32.9%, P<0.0001) and offspring events (35.4% versus 18.6%, P=0.008) than healthy women. Impaired UDF was associated with adverse obstetric and offspring outcome.
CONCLUSIONS: UDF parameters are abnormal in pregnant women with CHD. Cardiovascular function is associated with an abnormal pattern of UDF. Compromised UDF may be a key factor in the high incidence of offspring and obstetric complications in this population.

Entities:  

Keywords:  complications; congenital; heart diseases; placental circulation; pregnancy

Mesh:

Year:  2013        PMID: 24192800     DOI: 10.1161/CIRCULATIONAHA.113.002810

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  3-D volumetric MRI evaluation of the placenta in fetuses with complex congenital heart disease.

Authors:  Nickie Andescavage; Alexa Yarish; Mary Donofrio; Dorothy Bulas; Iordanis Evangelou; Gilbert Vezina; Robert McCarter; Adre duPlessis; Catherine Limperopoulos
Journal:  Placenta       Date:  2015-07-06       Impact factor: 3.481

2.  Maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease.

Authors:  Elizabeth J Eggleton; Catriona J Bhagra; Charlotte J Patient; Mark Belham; Janet Pickett; Catherine E Aiken
Journal:  Arch Gynecol Obstet       Date:  2022-06-03       Impact factor: 2.344

3.  Cardiovascular and Obstetric Delivery Complications in Pregnant Women With Valvular Heart Disease.

Authors:  Anum S Minhas; Faisal Rahman; Nicole Gavin; Ari Cedars; Arthur Jason Vaught; Sammy Zakaria; Jon Resar; Stefano Schena; Steven Schulman; Di Zhao; Allison G Hays; Erin D Michos
Journal:  Am J Cardiol       Date:  2021-08-24       Impact factor: 2.778

Review 4.  Preconception Counseling for Women with Congenital Heart Disease.

Authors:  Chun-Wei Lu; Mei-Hwan Wu; Jou-Kou Wang; Min-Tai Lin; Chun-An Chen; Shenn-Nan Chiu; Hsin-Hui Chiu
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

Review 5.  Pregnancy in a woman with a Fontan circulation: A review.

Authors:  Emily Moroney; Elske Posma; Alicia Dennis; Yves d'Udekem; Rachael Cordina; Dominica Zentner
Journal:  Obstet Med       Date:  2017-11-22

Review 6.  Use of medication for cardiovascular disease during pregnancy.

Authors:  Petronella G Pieper
Journal:  Nat Rev Cardiol       Date:  2015-12       Impact factor: 32.419

7.  Pregnancy outcomes in patients with structural heart disease: a single center experience.

Authors:  Eun-Young Choi; Eun Sun Kim; Jung-Yoon Kim; Min-Kyung Song; Seong-Ho Kim; Chung Il Noh
Journal:  Cardiovasc Diagn Ther       Date:  2021-02

Review 8.  Changes in vitelline and utero-placental hemodynamics: implications for cardiovascular development.

Authors:  Kersti K Linask; Mingda Han; Nathalie J M Bravo-Valenzuela
Journal:  Front Physiol       Date:  2014-11-11       Impact factor: 4.566

9.  Ischaemic heart disease during pregnancy or post-partum: systematic review and case series.

Authors:  H Lameijer; M A M Kampman; M A Oudijk; P G Pieper
Journal:  Neth Heart J       Date:  2015-05       Impact factor: 2.380

10.  Coronary flow reserve in pregnant rats with increased left ventricular afterload.

Authors:  Nils Thomas Songstad; Maria C Serrano; Vasilis Sitras; David Johansen; Davis Johansen; Kirsti Ytrehus; Ganesh Acharya
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.